Baylor College of Medicine clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 747 studies whose lead sponsor is Baylor College of Medicine. 111 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Baylor College of Medicine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Baylor College of Medicine leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Lymphoma, Non-Hodgkin26Diabetes Mellitus23Hodgkin Disease21Obesity19Depression18Lymphoma18Diabetes Mellitus, Type 117Obsessive-Compulsive Disorder17Substance-Related Disorders17Epstein-Barr Virus Infections15Diabetes Mellitus, Type 214Neuroblastoma14Cocaine-Related Disorders13Infections13Leukemia12Precursor Cell Lymphoblastic Leukemia-Lymphoma12Hookworm Infections11Leukemia, Myeloid, Acute11Heart Failure10Premature Birth10
Studies
Recruiting first, then most recently updated. Showing 50 of 747. Browse all 747 →
- Vitamin C With Steroids for Gastrointestinal GVHDNot yet recruitingNCT07197749Early Phase 1
- Cortical rTMS as a Treatment for DepressionRecruitingNCT05487911Not applicable
- Toddler Biomarker of Nutrition StudyNot yet recruitingNCT05855824Not applicable
- Food Prescription Among Youth With Type 1 DiabetesNot yet recruitingNCT07860229Not applicable
- Transcutaneous Vagus Nerve Stimulation for Attention and MemoryNot yet recruitingNCT06723743Not applicable
- Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's DiseaseNot yet recruitingNCT06835283Not applicable
- Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)RecruitingNCT01853631Phase 1
- Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for MesotheliomaRecruitingNCT05932199Phase 1/2
- CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)RecruitingNCT02917083Phase 1
- Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive LymphomasRecruitingNCT06176690Phase 1
- Genetic Inclusion by Virtual EvaluationRecruitingNCT05318222Not applicable
- Neurobehavioral Investigations of Approach Dynamics in the Ventral StriatumNot yet recruitingNCT05422469Not applicable
- The HIEnome Study: Genome Sequencing for Perinatal HIERecruitingNCT06762795Not applicable
- Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic StrokeRecruitingNCT06956521Phase 1
- Genetic Study to Determine the Cause of Birth Defects in Newborns in TexasRecruitingNCT07102966Not applicable
- GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive GlioblastomaRecruitingNCT06815432Phase 1
- Standardized Prenatal Clinical Care for LUTORecruitingNCT02315521
- Cooking HEalthy and Facilitating Early Childhood Development: CHEF-ED StudyRecruitingNCT06940817Not applicable
- TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast CancerRecruitingNCT06251544Phase 1
- Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in ChildrenRecruitingNCT07222943Not applicable
- Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)RecruitingNCT06345027Phase 1
- TETRAVI Expanded Access ProgramAvailableNCT07104591
- Postoperative Pain After Pediatric Adenotonsillectomy With Ketorolac or IbuprofenRecruitingNCT07672418
- Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)RecruitingNCT05010564Phase 1
- BBD Longitudinal Study of Osteogenesis ImperfectaRecruitingNCT02432625
- Clinical Evaluation of Montelukast in Veterans With Gulf War IllnessRecruitingNCT05992311Phase 1
- Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child StoryRecruitingNCT05809115
- UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AMLRecruitingNCT07059975Early Phase 1
- Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 AntigenRecruitingNCT03081910Phase 1
- Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot StudyRecruitingNCT07508124Phase 4
- Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsRecruitingNCT04715191Phase 1
- Telehealth Behavioral Activation for TeensRecruitingNCT06273995Not applicable
- Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic CancerRecruitingNCT05132504Phase 2
- CBT Augmentation to Promote Medication Discontinuation in Pediatric OCDRecruitingNCT05609916Not applicable
- C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)RecruitingNCT04099797Phase 1
- SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 DiabetesRecruitingNCT07674628Not applicable
- Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to NeuromodulationRecruitingNCT06596447Not applicable
- GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety StudyRecruitingNCT07723937
- NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or NeuroblastomaRecruitingNCT07211737Phase 1
- Leukemia Adapted ProtocolRecruitingNCT06928909
- Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic AdolescentsRecruitingNCT06943001Not applicable
- PATHS-UP Health Behavior Self-monitoring Mobile App for AdolescentsRecruitingNCT06959901Not applicable
- Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy PatientsRecruitingNCT05283811Not applicable
- Locating Biomarkers in OCD Through Behavioral TasksNot yet recruitingNCT03313622
- High Dose Albumin in Refractory AscitesRecruitingNCT05867602Phase 2
- Improving Comprehensive Care of Cancer PatientsRecruitingNCT05323409Not applicable
- WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOMEEnrolling by invitationNCT07387614Not applicable
- EBV Specific T-Lymphocytes for Treatment of EBV-Positive LymphomaRecruitingNCT04664179Phase 1
- Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)RecruitingNCT07496840
- TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.RecruitingNCT04013802Phase 1